Your browser doesn't support javascript.
loading
A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trial.
Le Cesne, A; Blay, J-Y; Cupissol, D; Italiano, A; Delcambre, C; Penel, N; Isambert, N; Chevreau, C; Bompas, E; Bertucci, F; Chaigneau, L; Piperno-Neumann, S; Salas, S; Rios, M; Guillemet, C; Bay, J-O; Ray-Coquard, I; Haddag, L; Bonastre, J; Kapso, R; Fraslin, A; Bouvet, N; Mir, O; Foulon, S.
  • Le Cesne A; Medical Oncology Department, Gustave Roussy, Villejuif, France. Electronic address: axel.lecesne@gustaveroussy.fr.
  • Blay JY; Medical Oncology Department, Centre Léon Bérard and Claude Bernard University, Lyon, France.
  • Cupissol D; Medical Oncology Department, Centre Val d'Aurelle, Montpellier, France.
  • Italiano A; Medical Oncology Department, Institut Bergonié, Bordeaux, France.
  • Delcambre C; Medical Oncology Department, Centre François Baclesse, Caen, France.
  • Penel N; Medical Oncology Department, Centre Oscar Lambret and Lille University, Lille, France.
  • Isambert N; Medical Oncology Department, Centre Georges-François Leclerc, Dijon, France.
  • Chevreau C; Medical Oncology Department, Institut Claudius Regaud, Toulouse, France.
  • Bompas E; Medical Oncology Department, Centre René Gauduchau, Nantes, France.
  • Bertucci F; Medical Oncology Department, Institut Paoli-Calmettes, Marseille, France.
  • Chaigneau L; Medical Oncology Department, Hôpital Jean Minjoz, Besancon, France.
  • Piperno-Neumann S; Medical Oncology Department, Insitut Curie, Paris, France.
  • Salas S; Medical Oncology Department, Hôpital La Timone, Marseille, France.
  • Rios M; Medical Oncology Department, Institut de Cancerologie de Lorraine, Nancy, France.
  • Guillemet C; Medical Oncology Department, Centre Henri Becquerel, Rouen, France.
  • Bay JO; Medical Oncology Department, Centre Jean Perrin, Clermont Ferrand, France.
  • Ray-Coquard I; Medical Oncology Department, Centre Léon Bérard and Claude Bernard University, Lyon, France.
  • Haddag L; Department of Radiology, Gustave Roussy, Villejuif, France.
  • Bonastre J; Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France; Oncostat U1018, Inserm, University Paris-Saclay, Labeled Ligue Contre le Cancer, Villejuif, France.
  • Kapso R; Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France; Oncostat U1018, Inserm, University Paris-Saclay, Labeled Ligue Contre le Cancer, Villejuif, France.
  • Fraslin A; Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France; Oncostat U1018, Inserm, University Paris-Saclay, Labeled Ligue Contre le Cancer, Villejuif, France.
  • Bouvet N; Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France.
  • Mir O; Medical Oncology Department, Gustave Roussy, Villejuif, France.
  • Foulon S; Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France; Oncostat U1018, Inserm, University Paris-Saclay, Labeled Ligue Contre le Cancer, Villejuif, France.
Ann Oncol ; 32(8): 1034-1044, 2021 08.
Article en En | MEDLINE | ID: mdl-33932507
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sarcoma / Tetrahidroisoquinolinas Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sarcoma / Tetrahidroisoquinolinas Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Año: 2021 Tipo del documento: Article